Page last updated: 2024-11-02

1,7-dimethylxanthine and Kwashiorkor

1,7-dimethylxanthine has been researched along with Kwashiorkor in 1 studies

1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.

Kwashiorkor: A syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in Gold Coast, Africa, meaning displaced child. Although first reported from Africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus. (From Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Caffeine-containing beverages are generally consumed by Nigerians suffering from malaria and kwashiorkor in the belief that caffeine aids early recovery from these illnesses, which are common in the tropics."9.09The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor. ( Akinyinka, OO; Honeywell, R; Renwick, AG; Sowunmi, A, 2000)
"Caffeine-containing beverages are generally consumed by Nigerians suffering from malaria and kwashiorkor in the belief that caffeine aids early recovery from these illnesses, which are common in the tropics."5.09The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor. ( Akinyinka, OO; Honeywell, R; Renwick, AG; Sowunmi, A, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akinyinka, OO1
Sowunmi, A1
Honeywell, R1
Renwick, AG1

Trials

1 trial available for 1,7-dimethylxanthine and Kwashiorkor

ArticleYear
The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor.
    European journal of clinical pharmacology, 2000, Volume: 56, Issue:2

    Topics: Administration, Oral; Caffeine; Child; Child, Preschool; Cytochrome P-450 CYP1A2; Female; Half-Life;

2000